Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01436240 · ClinicalTrials.gov registry record

Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
112
Enrollment target

NCT01436240: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01436240 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 112 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01436240 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
112 participants
Enrollment target

Study Summary

The purpose of this study is to see if questions in English about symptoms that patients may have during cancer treatment are understandable when translated into Spanish. These questions will later be used in future studies to give a better understanding of patient symptoms".

Primary Outcome

Patient Questionnaire (either via paper or read to them verbatim), and undergo a subsequent cognitive interview, as described in this protocol. Interviews will be conducted either by bilingual site staff who have been trained to conduct these interviews, or by trained bilingual interviewers from FACITtrans

Interventions

  • BEHAVIORAL questionnaire administration followed by cognitive interviews

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2011-09
Est. Completion 2017-05
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT01436240 record still lists

NCT01436240 is an observational study that tracks outcomes without assigning an intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which questionnaire administration followed by cognitive interviews is the first listed.

NCT01436240 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01436240 about?

NCT01436240 is a clinical study titled "Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)". The purpose of this study is to see if questions in English about symptoms that patients may have during cancer treatment are understandable when translated into Spanish. These questions will later be used in future studies to give a better understanding of patient symptoms".

What is the current status of trial NCT01436240?

This trial is currently completed. The enrollment target is 112 participants. The study started on 2011-09. Estimated completion is 2017-05.

What interventions are being tested in trial NCT01436240?

The interventions under investigation include: questionnaire administration followed by cognitive interviews (BEHAVIORAL).

Who is sponsoring clinical trial NCT01436240?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04511013 · 112 participants · Phase 2

    A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • NCT04551560 · 112 participants · NA

    Stress and Congestive Heart Failure

  • NCT04872166 · 112 participants · Phase 1

    A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

  • NCT05024773 · 112 participants · Phase 3

    Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01436240, the US trial registry maintained by the National Library of Medicine. NCT01436240 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.